SGI
GILD icon

Summit Global Investments’s Gilead Sciences GILD Stock Holding History

Summit Global Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
11,712
-339
-3% -$44.7K 0.08% 125
2026
Q1 		$1.68M Sell
12,051
-18,810
-61% -$2.63M 0.1% 109
2025
Q4 		$3.79M Sell
30,861
-14,468
-32% -$1.76M 0.22% 55
2025
Q3 		$5.03M Buy
45,329
+26
+0.1% +$2.96K 0.29% 54
2025
Q2 		$5.02M Buy
45,303
+10,233
+29% +$1.09M 0.3% 59
2025
Q1 		$3.93M Sell
35,070
-16,010
-31% -$1.65M 0.29% 56
2024
Q4 		$4.72M Buy
+51,080
New +$4.6M 0.3% 76
2024
Q2 		– Sell
-10,370
Closed -$760K – 529
2024
Q1 		$760K Sell
10,370
-91,720
-90% -$7.05M 0.06% 258
2023
Q4 		$8.27M Sell
102,090
-85,118
-45% -$6.62M 0.54% 38
2023
Q3 		$14M Buy
187,208
+2,687
+1% +$207K 0.93% 22
2023
Q2 		$14.2M Sell
184,521
-12,611
-6% -$1.01M 0.94% 19
2023
Q1 		$16.4M Sell
197,132
-26,443
-12% -$2.19M 1.27% 13
2022
Q4 		$19.2M Sell
223,575
-23,008
-9% -$1.82M 1.62% 9
2022
Q3 		$15.2M Buy
246,583
+46,740
+23% +$2.95M 1.41% 14
2022
Q2 		$12.4M Buy
199,843
+2,196
+1% +$136K 1.09% 22
2022
Q1 		$11.8M Buy
+197,647
New +$12.6M 0.87% 26
2020
Q3 		– Sell
-24,830
Closed -$1.91M – 257
2020
Q2 		$1.91M Buy
+24,830
New +$1.9M 0.22% 68
2017
Q2 		– Sell
-43,199
Closed -$2.93M – 256
2017
Q1 		$2.93M Sell
43,199
-195
-0.4% -$13.7K 0.96% 31
2016
Q4 		$3.11M Buy
+43,394
New +$3.23M 1.13% 28

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Summit Global Investments's GILD Position: Q2 2026 in Review

Summit Global Investments reduced its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, selling an estimated $44.7K and leaving 11,712 shares worth $1.48M. The position accounts for 0.08% of the portfolio, ranked #125.

Summit Global Investments first reported a position in GILD in Q4 2016 and has held it in 19 quarters since. The position peaked at $19.2M in Q4 2022. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Summit Global Investments held 11,712 shares of Gilead Sciences worth $1.48M as of Q2 2026.
  • Summit Global Investments sold 339 Gilead Sciences shares in Q2 2026, an estimated $44.7K.
  • Gilead Sciences made up 0.08% of Summit Global Investments's portfolio in Q2 2026, its #125 holding.
  • Summit Global Investments first reported a position in Gilead Sciences in Q4 2016 and has held it in 19 quarters since.
  • Summit Global Investments's Gilead Sciences position peaked at $19.2M in Q4 2022.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.